Orchestra BioMed (OBIO) News Today $3.15 +0.28 (+9.76%) Closing price 04:00 PM EasternExtended Trading$3.08 -0.07 (-2.22%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Orchestra BioMed (NASDAQ:OBIO) Given Sell (E+) Rating at Weiss RatingsOctober 10 at 8:22 AM | marketbeat.comOrchestra BioMed announces data summary supporting AVIM TherapyOctober 9 at 6:59 PM | msn.comOrchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation SummitOctober 9 at 8:00 AM | globenewswire.comOrchestra BioMed (NASDAQ:OBIO) vs. Regeneron Pharmaceuticals (NASDAQ:REGN) Critical SurveyOctober 5, 2025 | americanbankingnews.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of "Buy" by AnalystsSeptember 25, 2025 | marketbeat.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Short Interest Up 37.2% in AugustSeptember 17, 2025 | marketbeat.comHC Wainwright Expects Higher Earnings for Orchestra BioMedSeptember 9, 2025 | marketbeat.comOrchestra BioMed announces new data from AVIM therapy programSeptember 4, 2025 | msn.comOrchestra BioMed price target lowered to $10 from $12 at H.C. WainwrightSeptember 4, 2025 | msn.comOrchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation ...September 4, 2025 | markets.businessinsider.comOrchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following WashoutSeptember 4, 2025 | globenewswire.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Average Rating of "Buy" from AnalystsSeptember 1, 2025 | marketbeat.comInsider Buying: Orchestra BioMed (NASDAQ:OBIO) Insider Acquires 6,000 Shares of StockAugust 27, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Director Purchases $15,033.60 in StockAugust 27, 2025 | marketbeat.comOrchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical ElectrophysiologyAugust 26, 2025 | globenewswire.comInsider Buying: Orchestra BioMed (NASDAQ:OBIO) Insider Acquires 6,000 Shares of StockAugust 26, 2025 | insidertrades.comOrchestra BioMed (NASDAQ:OBIO) Given "Neutral" Rating at BTIG ResearchAugust 22, 2025 | marketbeat.comBTIG Downgrades Orchestra BioMed Holdings (OBIO)August 21, 2025 | msn.comOrchestra BioMed downgraded to Neutral from Buy at BTIGAugust 20, 2025 | msn.comOrchestra BioMed Reports Q2 2025 Financial ResultsAugust 19, 2025 | msn.comEquities Analysts Offer Predictions for OBIO FY2025 EarningsAugust 19, 2025 | marketbeat.comOrchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart DiseaseAugust 17, 2025 | msn.comOrchestra BioMed (NASDAQ:OBIO) Given "Buy" Rating at Chardan CapitalAugust 15, 2025 | marketbeat.comOrchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA MilestonesAugust 15, 2025 | msn.comOrchestra BioMed (NASDAQ:OBIO) Issues Earnings Results, Beats Estimates By $0.01 EPSAugust 14, 2025 | marketbeat.comOrchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic DysfunctionAugust 14, 2025 | globenewswire.comOrchestra BioMed reports Q2 EPS (50c), consensus (51c)August 12, 2025 | msn.comOrchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business UpdatesAugust 12, 2025 | finanznachrichten.deOrchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business UpdatesAugust 12, 2025 | globenewswire.comOrchestra BioMed rises as trial for antihypertensive drug expandsAugust 8, 2025 | msn.comOrchestra BioMed's (OBIO) Buy Rating Reiterated at Chardan CapitalAugust 8, 2025 | marketbeat.comOrchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient EligibilityAugust 8, 2025 | globenewswire.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Buy" by AnalystsAugust 6, 2025 | marketbeat.comDavid P. Hochman Purchases 20,000 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) StockAugust 5, 2025 | marketbeat.comOrchestra BioMed (OBIO) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comOrchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity OfferingsAugust 5, 2025 | globenewswire.comInsider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 20,000 Shares of StockAugust 5, 2025 | insidertrades.comOrchestra BioMed Secures $70 Million in Strategic Investments to Advance Cardiology PipelineAugust 3, 2025 | msn.comOrchestra BioMed Holdings, Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsAugust 1, 2025 | quiverquant.comQOrchestra BioMed Announces Pricing of $40 Million Public OfferingAugust 1, 2025 | globenewswire.comLigand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMedJuly 31, 2025 | finance.yahoo.comOrchestra BioMed Announces Proposed Public OfferingJuly 31, 2025 | globenewswire.comIFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)July 25, 2025 | marketbeat.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Buy" by BrokeragesJuly 12, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% - Here's What HappenedJuly 10, 2025 | marketbeat.comHedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year lossesJuly 2, 2025 | finance.yahoo.comOrchestra BioMed Confirms Director Elections and AuditorJune 24, 2025 | tipranks.comOrchestra BioMed Highlights Potential of AVIM Therapy for Managing Hypertension in High-Risk Patients at CSI 2025 MeetingJune 20, 2025 | nasdaq.comOrchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 MeetingJune 18, 2025 | msn.comOrchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025June 18, 2025 | globenewswire.com Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OBIO Media Mentions By Week OBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBIO News Sentiment▼0.440.78▲Average Medical News Sentiment OBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBIO Articles This Week▼63▲OBIO Articles Average Week Get the Latest News and Ratings for OBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DCTH News Today RXST News Today DRTS News Today NPCE News Today SNWV News Today TCMD News Today BWAY News Today SMTI News Today SI News Today CATX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OBIO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
